Neal Ready, MD

Neal Ready, MD, is a medical oncologist at Duke Cancer Center.

Articles by Neal Ready, MD

TMB, Tumor Burden, and Tailoring Immunotherapy in Lung Cancer

June 3rd 2026

Learn how TMB, PD-L1, smoking, and tumor burden shape first-line lung cancer immunotherapy choices, including when to add chemo or CTLA-4.

Checkpoint Inhibitors in Lung Cancer: When One Drug Isn't Enough

ByNeal Ready, MD

May 21st 2026

During a live Case-Based Roundtable event, Neal Ready, MD, dicussed the rationale for adding an anti–CTLA-4 agent to an anti–PD-1/PD-L1 backbone in NSCLC.

Latest Updated Articles

Checkpoint Inhibitors in Lung Cancer: When One Drug Isn't Enough
May 21st 2026

Neal Ready, MD

Articles by Neal Ready, MD

TMB, Tumor Burden, and Tailoring Immunotherapy in Lung Cancer

Checkpoint Inhibitors in Lung Cancer: When One Drug Isn't Enough

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

Long-Term OMNIVORE Data Show Durable Treatment-Free Survival in RCC

Phase 3 ENHANCE Trial: Magrolimab Adds Toxicity, Not Benefit, in MDS

First Patients Dosed With TLX597-Tx in Trial for mHSPC

Advanced Renal Cell Carcinoma: Summarizing a Practical First-Line Treatment Algorithm

On-Body Injector Technology Streamlines Subcutaneous Myeloma Therapy